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determine whether uterine mast cells (UMC) have a pattern of surface antigens different from those previously reported for other human mast cell types. In addition, the effect of purification procedures on the ability of these mast cells to release histamine in response to secretagogues is examined.
MATERIALS AND METHODS
Human UMCpunfication. Human uterine tissue was obtained from hysterectomy specimens and dispersed as previously described''' using Type 11 collagenase (200 UImL, 37"C, 6 to 8 hours; Worthington Biochemical, Freehold, NJ). Cells were then subjected to two sequential gradient centrifugation steps using discontinuous gradients of Percoll (Pharmacia, Uppsala, Sweden) as de~cribed.'~ Purity of the mast cell suspensions before density gradient centrifugation was always less than 1% as assessed by light microscopy after alcian blue staining. Purity after density gradient centrifugation, as assessed in cytocentrifugation specimens after staining with alcian blue and counterstaining with safranin, ranged between 50% and 95% (81% 2 7%, mean * SEM, n = 10; Fig 1) .
Recovery of mast cells from the starting tissue, based on measurements of histamine content before and after purification, is approximately 10%.'" Mouse monoclonal antibodies (MoAbs; see Table 1 for specific clones and isotypes) recognizing the following surface structures were purchased: HLA class I (Accurate Chemical, Westbury, NY); CD9, CDllc, CD29, CD32, CD49b, CD49d, CD49e, CD49f, CD51, CD54, and CD61 (AMAC Inc, Westbrook, ME); CDIlc, CD14, CD43, and necessary, cells were subsequently incubated with PE-conjugated polyclonal goat antimouse IgG (Tago, Burlingame, CA). Using an EPICS Profile Flow Cytometer (Coulter), initial gating was performed using forward and side scatter to eliminate debris and identify a uniform population of mast cells. A total of 1,000 to 5,OOO mast cell events were collected, and histograms and the percentage of cells with a fluorescence intensity 295% of all control events (percent positive) were determined. UMC adherence assays. Endothelial cells were isolated from human umbilical cord veins by an adaptation'" of previously described methods." Cells were routinely subdivided and grown to confluence in 24-well tissue culture plates containing M199 media supplemented with antibiotics, heparin, and endothelial cell growth factor as described" for use in subsequent assays. No cell lines were used after the third serial passage. Endothelial cells were identified by their typical cobblestone morphology and the presence of factor VI11 antigen with indirect immunofluorescence as described.I9 UMC adherence was performed essentially as previously reported for human basophils?"" In brief, wells containing confluent endothelial cell monolayers were incubated in the presence or absence of recombinant human interleukin-1 (IL-1; 5 nglmL for 4 hours at 37"C, generously provided by Dr Steven Gillis, Immunex, Seattle, WA), washed, and 100 pL of a suspension of purified UMC (70% to 95% purity, 20,000 total UMC) was added to duplicate wells. Cells were allowed to incubate for 10 minutes at 37T, at which time nonadherent cells were rinsed away, and the histamine content of perchlorate lysates of adherent cells was used to quantitate basophil binding.'Lu Mast cells of lower or higher purity were incubated for 45 minutes at 37°C as described'" in the presence or absence of polyclonal goat antihuman IgE, the calcium ionophore A23187, or mouse monoclonal antihuman CD32 (IV.3, antiFcyRII; Table 1 ). Histamine in cell-free supernatants was measured using an automated fluorometric assay." Histamine release.
RESULTS
Using immunofluorescence and flow cytometry, we determined the surface expression of a variety of antigens (Table 1) . Consistent with previous reports examining surface markers on human lung mast cells (summarized in molecules present on UMC included the p l integrins very late activation antigen-4 (VLA-4) (CD49d/CD29, a counterreceptor for vascular cell adhesion molecule-1 [VCAM-11) and VLA-5 (CD49e/CD29, a receptor for fibronectin), as well as one of the p3 integrins referred to as the vitronectin receptor (CD51/CD61). Expression of the selectin LECAM-1 (recognized by the Leu-8 antibody) and the a subunits of the collagen receptor (CD49b) and the laminin receptor (CD49f) was not detected. Representative flow cytometric histograms for surface markers present on human UMC are shown in Fig 2. Adherence of human UMC to cytokine-activated endothelial cells. Treatment of human umbilical vein endothelial cells with IL-1 is known to induce the expression of a number of adhesion molecules, including intercellular adhesion molecule-1 (ICAM-l), endothelial cell adhesion molecule-1 (ELAM-l), and VCAM-1.23-26 Experiments were performed to determine whether such treatment resulted in enhanced adhesiveness for UMC. In two separate experiments, treatment of endothelial cells for 4 hours with 5 ng/mL IL-1 resulted in an increase in UMC adherence from 2.4% 2 0.6% to 6.5% f 1.1% (mean f SEM).
To determine whether these purification procedures altered histamine releasability from human UMC, cells were challenged with polyclonal goat antihuman IgE or the calcium ionophore A23187 immediately after dispersement with collagenase (purity I 1%) or after enrichment on Percoll gradients (purity 295%). As shown in Fig 3, the histamine release responses to anti-IgE or calcium ionophore A23187 were not altered as a result of purification procedures. In separate experiments, treatment of UMC with saturating and subsaturating concentrations of MoAb IV.3 (anti-CD32, FcyRII) did not induce histamine release or alter anti-IgE-induced release (n = 4, data not shown).
Histamine release from purified human UMC. 
DISCUSSION
Methods for the isolation and purification of human mast cells from uterine tissues have permitted the phenotypic and functional analysis of this cell type for comparison with other previously isolated mast cells. Using immunofluorescence and flow cytometry, human UMC were found to express many surface antigens previously found on mast cells from other Some are relatively specific for the mast cell (IgE, the c-kit receptor recognized by MoAb YB5.B8"~'7) while others are expressed on leukocytes and other cells. Among the panel of surface antigens analyzed, any surface marker previously found on other mast cell types4327 was also expressed on UMC. In contrast to other Fluorescence intensity mast cells, the p2 integrin p150,95 (CDllc/CD18) and one type of low-affinity receptor for IgG (FcyRII, CD32) were detected on human UMC and confirmed using two different monoclonals recognizing different epitopes on these m 0 1 e c u l e s .~~~~~~ With respect to the possible function of these surface molecules, data presented herein showed that treatment of human mast cells with IV.3 antibody (anti-CD32) failed to induce histamine release or alter anti-IgEinduced release. Although the exact functions of these structures on mast cells remain to be determined, the roles, on other cell types, of p150,95 (in cell adhesion) and FcyRII (in binding to aggregated IgG) are well documented.2Y-3' While the expression of these molecules on UMC provides evidence in support of mast cell heterogeneity, it is possible that purification techniques used for mast cells from other tissues, including the use of proteases, may alter specific epitopes recognized by the MoAbs. It is interesting to note, however, as has been suggested by Valent et a1 for other mast cell~,4,~' that UMC display a number of surface antigens found on macrophages. This finding is true for CDllc/CDl8, CD9, CD32, CD33, and others, and suggests a possible linkage between the lineage of mast cells and monocytes. The recent report that human skin mast cells may contain and release tumor necrosis factor, a cytokine produced by monocytes and macrophages, is also consistent with this concept.32
The recent availability of MoAbs recognizing the pl and p3 families of the integrin supergene family has now permitted analysis of expression of several of these surface antigens in immunophenotyping studies of mast cells. Expression of VLA-4 and VLA-5 a (CD49d and CD49e) and its common p subunit (CD29) was detected, as was expression of the a and p subunits of the vitronectin receptor (CD51/CD61). These results, along with the identification of p150,95 and absence of the selectin LECAM-1, recognized by MoAb Leu-8, are particularly intriguing in view of recent studies showing human mast cell migration in vivo, and chemotaxis and adhesion of mouse mast cell lines to laminin but not collagen or fibronectin in ~i t r o .~~"~ Although the expression of VLA-2, a receptor known to bind both collagen and laminin, and VLA-6 (the so-called laminin receptor) could not be detected on UMC, it is possible that binding to laminin occurs through other receptors such as VLA-1 or VLA-3 that were not analyzed in the present
In addition, the fact that UMC bind to IL-1-activated endothelial cells and express p150,95, VLA-4, and VLA-5 suggests that these cells may interact with various ligands including an as yet unidentified cytokineinducible counter-receptor for CD1 l~/CD18,9~ the endothelial cell activation molecule VCAM-1 (recognized by VLA-426), and the carboxy terminal connecting segment CS-1 region and arg-gly-asp (or RGD)-containing regions of fibronectin (recognized by VLA-4 and VLA-5, respect i~e l y ) ?~,~~ The vitronectin receptor (CD51/CD61), found on platelets, endothelium, tumor cells, and other cell types, is capable of binding to a variety of ligands in addition to vitronectin, including von Willebrand factor, fibrinogen, thrombospondin, and others.36 If in fact mast cells are capable of binding to specific extracellular matrix and endothelial cell proteins, this interaction may contribute to the localization of mast cells near vascular endothelium in many tissues. It is anticipated that further studies involving more extensive analysis of adherence responses will shed additional light on the function of human mast cell integrins and perhaps other adhesion molecules.
